{
  "trial_id": "NCT00356512",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "Adult hypoparathyroid patients",
      "label": "met",
      "evidence": "patient text"
    },
    {
      "criterion": "on a stable treatment regimen of calcitriol and calcium supplementation",
      "label": "met",
      "evidence": "patient text"
    },
    {
      "criterion": "willing to participate in the study",
      "label": "met",
      "evidence": "patient text"
    },
    {
      "criterion": "Adult PHP1B patients as defined by the clinical syndrome of elevated PTH and phosphorus",
      "label": "unknown",
      "evidence": "none"
    }
  ],
  "exclusion": [
    {
      "criterion": "Renal insufficiency as evidenced by a creatinine clearance of less than 50 ml/min",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "Medically unstable patients",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Uncontrolled comorbid conditions, e.g., diabetes, coronary artery disease, congestive heart failure, or cerebrovascular disease.",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "Digitalis therapy",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Patients on diuretic therapy, especially thiazides",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Pregnant and lactating women",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "Patients whose hypoparathyroidism is caused by severe calcium-sensing receptor defects.",
      "label": "unknown",
      "evidence": "none"
    }
  ],
  "notes": "Patient has unremarkable past medical and drug history, BMI of 23, BP: 120/75, HR: 75/min. Laboratory study shows Vit D: 14ng/ml.",
  "_meta": {
    "topic_id": "53",
    "trial_id": "NCT00356512",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}